Latest News


Congratulations Professor Rob Baxter.

Former Kolling Institute director Professor Rob Baxter received an Order of Australia medal in the Queen’s Birthday honour roll for his significant service to medical research, endocrinology and tertiary education. Professor Baxter has more than 20 years experience in breast cancer research, with expertise in cell biology, endocrinology and metabolic regulation. He has been a Professor in the Sydne.....
Read more

Category: Awards

New investment in innovative approach to osteoarthritis treatment.

Key research into the treatment of osteoarthritis is set to be strengthened with the Kolling’s Professor David Hunter receiving a large NHMRC investigator grant. The highly competitive grant was awarded to the Florance and Cope Chair of Rheumatology for a five-year project to transform treatment options and delivery of care for osteoarthritis. Professor Hunter welcomed the grant, saying osteoarthri.....
Read more

Category: Funding support

Research may lead to early warning test for COVID-19.

For many people with COVID-19, the first sign they had the virus was a loss in their sense of smell. Now a team from the Kolling Institute and Royal North Shore Hospital will investigate the correlation between the virus and early symptoms. Study lead Associate Professor Rory Clifton-Bligh said a loss of smell has emerged as a common symptom of COVID-19 infection, but the current data is relying on.....
Read more

Category: Research Excellence

Co-ordinated COVID-19 Research Response.

Kolling Institute researchers are a key part of a new Northern Sydney Local Health District COVID-19 Clinical Research Group. All major specialist disciplines are represented in the group, taking advantage of the breadth of knowledge across the health campus. Kolling researcher Associate Professor Clifton-Bligh said we formed the group because we saw a clear need to co-ordinate our clinical resear.....
Read more

Category: Research Excellence

Important national COVID-19 study.

For many people with heart disease there’s an increased level of anxiety around the implications of COVID-19, but it’s hoped a new study led by Royal North Shore Hospital will guide future treatment and improve health outcomes. Head of cardiology Professor Ravinay Bhindi has launched the AUS-COVID study, which will involve more than 800 patients in over 20 hospitals across Australia. The Kolling I.....
Read more

Category: Research Excellence

Multiple medications cause frailty, but this can be reversed .

A world-first study by a team from the Kolling Institute may inform the future use of multiple medications by older people, minimising adverse impacts including frailty. The longitudinal research is the first preclinical study to demonstrate that multiple medications can impair function in old age, and that stopping some can reduce harm. Research lead, Professor Sarah Hilmer said until now there’s.....
Read more

Category: Research Excellence

Celebrating 100 years of research excellence.

2020 is an important year for the Kolling Institute as it marks the 100 year anniversary of the research organisation. As the longest-running medical research institute in New South Wales, the Kolling has a very rich history. Originally named the Institute of Pathological Research of NSW, the organisation was established in a cottage within the grounds of Royal North Shore Hospital in 1920. Bioche.....
Read more

Category: Research Excellence

Valuable biobanking resource improving health outcomes and strengthening research.

For nearly three decades, the Kolling Institute Tumour Bank has been quietly and consistently building a large state resource. It was established in 1992 with a small number of endocrine tumours. Today, it also has breast, colorectal and gynaecological tumour collections, as well as neurological and gastrointestinal samples. The significance of the resource has been recognised in recent years, and.....
Read more

Category: Research Excellence

New funding to help reduce Australia’s bowel cancer rates .

Professor Mark Molloy’s ground-breaking bowel cancer research has received a boost, with the Cancer Council NSW awarding the Kolling Institute researcher a three-year $450,000 grant. Professor Molloy has welcomed the funding, saying bowel cancer claims more lives each year than breast, prostate or skin cancer. “It is now Australia’s second biggest cancer killer, with more than 300 Australians diagn.....
Read more

Category: Funding support

Newsletter.


Read more

Category: Newsletters